Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 12, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals on October 11, 2005, at a price of GBP 14.48 per share through the Company's ShareReward Plan. The transactions involve:
- Mr J S Heslop: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr R Bondy: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr A P Witty: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mrs J V Younger: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
These acquisitions arose from the partnership and matching elements of the Plan entered into on October 5, 2001.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Share price for the transaction was GBP 14.48 per Ordinary Share.
- Transactions occurred on October 11, 2005, and were notified on October 12, 2005.
- Four senior individuals participated in the ShareReward Plan matching scheme.
- Total shares acquired per individual was 18 (9 personal + 9 matched).